---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039516"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T19:10:55.235851+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nephros appoints Judy Krandel as CFO; Andrew Astor resigns effective Nov 1, 2023

## Summary
- Judy Krandel appointed CFO effective Nov 1, 2023, replacing Andrew Astor.
- Krandel receives base salary $140k, 25% bonus target, and inducement option for 122,524 shares at $1.71.
- Option vests 25% on first anniversary, then quarterly over 4 years.
- Astor remains through Dec 31, 2023 to assist transition.

## SEC filing metadata
- accession: 0001493152-23-039516
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315223039516/0001493152-23-039516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315223039516/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039516
- JSON: https://secwatch.observer/filing/0001493152-23-039516.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039516.txt

## Key facts
- Executive change
  Judy Krandel was appointed as Chief Financial Officer at NEPHROS INC.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Nephros, Inc. (the “Company”) appointed Judy Krandel as its Chief Financial Officer, effective November 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1196298/000149315223039516/0001493152-23-039516-index.htm
- Executive change
  Andrew Astor resigned as Chief Financial Officer at NEPHROS INC.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On November 1, 2023, in connection with Ms. Krandel’s appointment as Chief Financial Officer, Andrew Astor resigned as the Company’s Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1196298/000149315223039516/0001493152-23-039516-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.